David Talenfeld, J.D., MBA, MGM

David Talenfeld, J.D., MBA, MGM is is Market and Portfolio Analyst at BioAccel and Managing Member at Botanisol™ Holdings.
 
BioAccel is a 501(c)3 non-profit organization that creates vibrant communities by transforming discoveries into new companies, new jobs, and new products. They achieve this through their three strategic priorities (outcomes):

• Diversified Economic Growth
• Improved Health
• Entrepreneurial Education and Outreach

By leveraging philanthropic support for startups rather than traditional funding, BioAccel has developed an innovative approach that serves as a promising model for organizations dedicated to technology-driven economic development.
 
Botanisol Holdings is a company whose lean, IP asset-centric portfolio approach emphasizes mutually beneficial public-private partnerships for the development of safer more effective drugs, affordable to underserved populations. Their mission is to advance public health by demonstrating exemplary stewardship in the management of federally funded research outcomes and honor their commitment to making higher education “as nearly free as possible” for future generations.
 
Dave earned his B.A. in International Studies at the University of Arizona in 2007. He earned his J.D. at the University of Arizona, James E. Rogers College of Law in 2011. He earned his MBA at the University of Arizona, Eller College of Management in 2011. He earned his MGM in Global Management and Entrepreneurship at the Thunderbird School of Global Management in 2011.
 
View his Facebook page. Read his LinkedIn profile.